Serentrix Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Serentrix General Information
Description
Developer of targeted small molecule therapies designed for innocuous pain relief without the risk of addiction. The company focuses on an approach that utilizes specially designed molecules to target specific pain pathways in the body, enabling clinicians and patients to have effective pain management without the addictive properties often associated with traditional pain medications.
Contact Information
Website
www.serentrix.comCorporate Office
- 1 East Uwchlan Avenue
- Suite 301
- Exton, PA 19341
- United States
Corporate Office
- 1 East Uwchlan Avenue
- Suite 301
- Exton, PA 19341
- United States
Serentrix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 13-Sep-2023 | Completed | Clinical Trials - Phase 1 | |||
| 1. Accelerator/Incubator | 18-Feb-2022 | Completed | Clinical Trials - Phase 1 |
Serentrix Patents
Serentrix Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2552888-A1 | "trpv1 vanilloid receptor antagonists with a bicyclic portion" | Active | 30-Mar-2010 | ||
| EP-2552888-B1 | Trpv1 vanilloid receptor antagonists with a bicyclic portion | Active | 30-Mar-2010 | ||
| US-10233177-B2 | Trpv1 vanilloid receptor antagonists with a bicyclic portion | Active | 30-Mar-2010 | ||
| US-20130079339-A1 | Trpv1 vanilloid receptor antagonists with a bicyclic portion | Active | 30-Mar-2010 | ||
| US-20160289199-A1 | Trpv1 vanilloid receptor antagonists with a bicyclic portion | Inactive | 30-Mar-2010 | C07D413/14 |
Serentrix Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| The Innovation Space | Accelerator/Incubator | |||
| PitchHU | Accelerator/Incubator |
Serentrix FAQs
-
When was Serentrix founded?
Serentrix was founded in 2014.
-
Where is Serentrix headquartered?
Serentrix is headquartered in Exton, PA.
-
What industry is Serentrix in?
Serentrix’s primary industry is Drug Discovery.
-
Is Serentrix a private or public company?
Serentrix is a Private company.
-
What is Serentrix’s current revenue?
The current revenue for Serentrix is .
-
Who are Serentrix’s investors?
The Innovation Space and PitchHU have invested in Serentrix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process